A Review on Anticancer Activity of 1, 3, 4-oxadiazole
Keywords:
1, 3, 4-oxadiazole, Anticancer, Drug resistanceAbstract
In this review we are presenting the Anticancer activity of the 1, 3, 4 Oxadiazole. Designing new anti-cancer drugs with high efficiency and broad spectrum activity is a significant need of today. Drug resistance, generally caused because of long term cancer treatment is rapidly becoming a major worldwide problem. The design of new compounds to deal with the resistance problem has become one of the most important goals of anti-cancer research today. This review article describes the anticancer activity of 1, 3, 4 Oxadiazole ring being reported on various cancer cell lines and will be useful in guiding the researchers across the world working on this moiety and consequently will be instrumental in the advancement of 1, 3, 4-oxadiazole chemistry.
Downloads
References
G Mathur, S Nain, PK Sharma, “Cancer: An Overview”. Acad. J. Cancer Res. 2015;8: 1 9336.
K Nepali, S Sharma, “Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids”. Eur. J. Med. Chem. 2014;77: 422–487.
www. World Health Organization. Com.
RR Somani, PY Shirodka, Der. Pharma. Chemica. 2009;1(1): 130-140.
BS Orlek, FE Blaney, Comparison of azbicyclic esters and oxadiazole as ligands for the muscarinic receptors, P. J. Med. Chem. 1991; 34: 2726.
A Aziz-ur-Rehman, N Fatima, MA Abbas, KM Abbasi, M Khan, IA Ashraf, Synthesis, characterization and biological screening of 5-substituted-1,3,4-oxadiazole-2yl-N-(2-methoxy-5-chlorophenyl)-2-sulfanyl acetamide. Pak. J. Pharm. Sci. 2013;26: 345–352.
SZ Aziz-ur-Rehman, N Siddiqui, MA Abbas, KM Abbasi, MKhan, SY Mahmood, Synthesis, antibacterial screening and hemolytic acitvity of S-substituted derivatives of 5-benzyl-1,3,4-oxadiazole-2-thiol. Int. J. Pharm. Sci. 2012;4: 676–680.
B Shivi, M Gupta, 1, 3, 4-oxadiazole as antimicrobial agents, Journal of Chemistry and Pharmaceutical Research. 2011; 3(3): 137-147.
MO Ahmed, A Mahmud, T Hasan, T Mahmoud, Synthesis, antibacterial, antifungal and genotoxic activity of bis-1,3,4-oxadiazole derivatives, Polish Journal of Pharmacology. 2002;54: 55?59.
C Rakesh, A Anshu, KP Manoj, CS Prabodh, M Sukumar, KR Thengungal, Synthesis of novel 1,3,4-oxadiazole derivatives as potential antimicrobial agents, Act Poloniae Pharmaceutica-Drug Research. 2010;3(67): 247-253.
NN Farshori, MR Banday, A Ahmad, AU Khan, A Rauf, Synthesis, characterization, and in vitro antimicrobial activities of 5-alkenyl/hydroxyalkenyl-2-phenylamine-1,3,4-oxadiazoles and thiadiazoles, Bioorganic & Medicinal Chemistry Letter. 2010;20: 1933-1938.
N Bhardwaj, P Saraf, SK Sharma, P Kumar, Synthesis, evaluation and characterization of 1,3,4oxadiazoles as antimicrobial agents, Eur. Journal of Chemistry. 2009;6(4): 1133?38.
HS Yathirajan, MN Anil, B Narayana, BK Sarojini, S Kumari, Synthesis and antimicrobial studies on new substituted 1,3,4?oxadiazole derivatives bearing 6?bromonaphthalene moiety. International Journal of Chemistry. 2010;2(1): 38?54.
O Parkash, M Kumar, C Sharma, KR Aneja, Hypervalent iodine (III) mediated, synthesis of novel unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles as antibacterial and antifungal agents. European Journal of Medicinal Chemistry. 2010;45(9): 4252-4257.
B Madhavilatha, D Bhattacharjee, G Sabitha, BVS Reddy, JS Yadav, N Jain, BJM Reddye, Synthesis and in vitro anticancer activity of novel 1,3,4-oxadiazole linked 1,2,3-Triazole/Isoxazole hybrids, Journal of Heterocyclic Chemistry. 2018;1-8.
FAF Ragab, M Sahar, Design, synthesis and anticancer activity of new monastrol analogues bearing 1,3,4 oxadiazole moiety. 2017: 2-21.
J Slawinski, K Szafranski, A Pogorzelska, B Zolnowska, Novel 2-benzylthio-5-(1,3,4-oxadiazol-2-yl)benzenesulfonamides with anticancer activity, Synthesis, QSAR study, and metabolic stability, European Journal of Medicinal Chemistry. 2017;132: 236-248.
PP Roy, S Bajaj, TK Maity, Synthesis and evaluation of anticancer activity of 1, 3, 4-oxadiazole derivatives against ehrlich ascites carcinoma bearing mice and their correlation with histopathology of liver, Indian Journal of Pharmaceutical Education and Research. 2017;51(2): 260-269.
J Sun, SZ Ren, XY Lu, JJ Li, FQ Shen, C Xu, HL Zhu, Discovery of a series of 1,3,4-oxadiazole-2(3H)-thione derivatives containing piperazine skeleton as potential FAK inhibitors, Bioorganic & Medicinal Chemistry. 2017;1-24.
WA Elsayed, WI Elsofany, HAR Hussein, NM Fathi, Synthesis and anticancer activity of new [(Indolyl)pyrazolyl]-1,3,4-oxadiazole thioglycosides and acyclic nucleoside analogs, Nucleosides, Nucleotides and Nucleic Acids. 2017;1-23.
N Polkam, B Kummari, P Rayam, U Brahma, VGM Naidu, S Balasubramanian, JS Anireddy, Synthesis of 2,5-Disubstituted-1,3,4-oxadiazole Derivatives and Their Evaluation as Anticancer and Antimycobacterial Agents, ChemistrySelect. 2017;2: 5492-5496.
O Francesco , D Simona, F Cristina, Drug design, synthesis, in vitro and in silico evaluation of selective mono amino oxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffold, European Journal of Medicinal Chemistry. 2016;108: 542-552.
JDS Chaves, LG Tunes, CHdeJ Franco, TM Francisco, CC Correa, Novel gold(I) complexes with 5-phenyl-1,3,4-oxadiazole-2-thione and phosphine as potential anticancer and antileishmanial agents, European Journal of Medicinal Chemistry. 2016;1-28.
S Kavitha, K Kannan, S Gnanavel, Synthesis, characterization and biological evaluation of novel 2, 5 substituted- 1, 3, 4 oxadiazole derivatives, Saudi Pharmaceutical Journal. 2016;1-26.
B Mochona, X Qi, S Euynni, D Sikazwi, N Mateeva, KF Soliman, Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents, Bioorganic & Medicinal Chemistry Let-ters.2016;1-5.
VR Pidugu, NS Yarla, SR Pedada, AM. Kalle, Design and synthesis of novel HDAC8 inhibitory 2,5-disubstituted-1,3,4-oxadiazoles containing glycine and alanine hybrids with anticancer activity, Bioorganic & Medicinal Chemistry. 2016;24: 5611–5617.
S Raju D, TNV Ganesh Kumar, J Mathew, Jeyaprakash, Synthesis & biological evaluation of 1, 3, 4- oxadiazoles as anticancer agents, Indo Global Journal of Pharmaceutical Sciences. 2015;5(1): 1-5.
DQ Qi, CM Yu, JZ You, GH Yang, XJ Wang, YP Zhang. Synthesis, crystal structures, fluorescence and xanthine oxidase inhibitory activity of pyrazole-based 1, 3, 4-oxadiazole derivatives, Journal of Molecular Structure. 2015;8: 421.
M Rashid, A Husain, R Mishra, S Karim, S Khan, M Ahmad, N Al-wabel, et al. Design and synthesis of benzimidazoles containing substituted oxadiazole, thiadiazole and triazolo-thiadiazines as a source of new anticancer agents, Arabian Journal Chemistry. 2015.
F Zhang, XL Wang, J Shi, SF Wang, Y Yin, YS Yang, WM Zhang, HL Zhu, Synthesis, molecular modelling and biological evaluation of N-benzylidene-2-(5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio) acetohydrazide derivatives as potential anticancer agents, Bioorganic & Medicinal Chemistry. 2014;22: 468–477.
S Valente, D Trisciuoglio, TD Luca, A Nebbioso, D Labella, A Lenoci, C Bigogno, et al. 1,3,4-oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells, J. Med. Chem.2014; 57: 6259?6265.
K Zhang, P Wang, LN Xuan, XY Fu, F Jing, YM Liu, BQ Chen, Synthesis and antitumor activities of novel hybrid molecules containing 1,3,4-oxadiazole and 1,3,4-thiadiazole bearing Schiff base moiety, Bioorg. Med. Chem. 2014;24(22): 5154-5156.
SA Shahzad, M Yar, M Bajda, B Jadoon, et al. Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agents, Bioorganic & Medicinal Chemistry. 2014;22: 1008–1015.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
